Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials
Introduction Immunotherapy has reshaped the adjuvant landscape, with several immune checkpoint inhibitors (ICIs) approved in different tumor types. This meta-analysis evaluates the benefit of adjuvant ICIs across solid tumors. Methods A systematic literature search of PubMed, Embase, the Cochrane Central Register of Co...